VV

Versant Venture Management, LLC

13F
Versant Venture Management, LLC
Last update 2024-08-07 8 Stocks (1 new)
Value $77.00 Mil Turnover 21 %
Countries:
Top Holdings: CRSP(34.84%)CTNM(20.92%)SKYE(20.81%)RPTX(11.30%)ADVM(4.50%)
Portfolio Report
Summary Stock Picks Current Portfolio
Versant Venture Management, LL... Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
CRSP 		CRISPR Therapeutics AG
498,558
26927.120
0%
34.840
0%
0.590
+1.41%
-19.55%
4298.401
Biotechnology
CTNM 		Contineum Therapeutics Inc
918,163
16168.850
New Holding
20.920
+20.92%
3.570
-1.72%
0%
427.006
Biotechnology
SKYE 		Skye Bioscience Inc
2,007,704
16081.710
0%
20.810
0%
7.150
-3.95%
+96.69%
162.310
Biotechnology
RPTX 		Repare Therapeutics Inc
2,646,657
8733.970
0%
11.300
0%
6.230
+25.00%
-46.58%
165.538
Biotechnology
ADVM 		Adverum Biotechnologies Inc
506,821
3476.790
0%
4.500
0%
2.440
+14.88%
+2.55%
160.583
Biotechnology
PASG 		Passage Bio Inc
4,026,417
3197.780
-18.82%
4.140
-1.22%
6.530
-26.87%
-38.46%
38.395
Biotechnology
GRTSQ 		Gritstone Bio Inc
3,561,150
2200.440
0%
2.850
0%
3.280
-95.30%
-98.79%
2.917
Biotechnology
ALGS 		Aligos Therapeutics Inc
58,317
510.280
-37.17%
0.660
-0.82%
1.870
-14.48%
-40.78%
31.418
Biotechnology

Versant Venture Management, LLC's Historical Top Holdings Breakdowns

Versant Venture Management, LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
CTNM 		Contineum Therapeutics Inc2024-06-30New Buy
+20.92%
●
14.09 ($16.1) 20.8
$16.60
3.11%
New holding
918,163
918,163
PASG 		Passage Bio Inc2024-06-30Reduce
-1.22%
●
0.79 ($1.22) 1.58
$0.62
-49.05%
Reduce -18.82%
4,026,417
-933,352
ALGS 		Aligos Therapeutics Inc2024-06-30Reduce
-0.82%
●
8.75 ($17.58) 26.75
$9.83
-44.08%
Reduce -37.17%
58,317
-862,444
RYZB RayzeBio inc2024-03-31Sold Out
-82.47%
●
61.81 ($62.18) 62.49
$62.49
0.50%
Sold Out
0
-5,158,161
SKYE 		Skye Bioscience Inc2024-03-31New Buy
+30.45%
●
2.25 ($7.75) 18
$5.35
-30.97%
New holding
2,007,702
2,007,702
UTRS 		Minerva Surgical Inc2023-12-31Sold Out
-0.15%
●
1.17 ($2.41) 3.31
$0.01
-99.50%
Sold Out
0
-4,184
RYZB RayzeBio inc2023-09-30New Buy
+60.87%
●
18.51 ($20.99) 24
$62.49
197.71%
New holding
5,158,161
5,158,161
CBAY CymaBay Therapeutics Inc2023-09-30Sold Out
-7.06%
●
10.86 ($13.26) 17.62
$32.48
144.95%
Sold Out
0
-543,753
UTRS 		Minerva Surgical Inc2023-09-30Reduce
-0.51%
●
3.29 ($4.55) 6.07
$0.01
-99.74%
Reduce -99.75%
4,184
-33,390,316
RPTX 		Repare Therapeutics Inc2023-06-30New Buy
+33.22%
●
8.63 ($10.3) 12.53
$3.90
-62.14%
New holding
2,646,657
2,646,657

Versant Venture Management, LLC Total Holding History ($B)

To

Versant Venture Management, LLC's Asset Allocation

To

Versant Venture Management, LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Versant Venture Management, LLC's Hypothetical Growth since 2024-06-30

Versant Venture Management, LLC's Yearly Returns

Year Portfolio % % Excess Gain %

Versant Venture Management, LLC's Holdings Heat Map

Size field:

Versant Venture Management, LLC's Holdings Bubble Chart

Versant Venture Management, LLC News

  • 1

Discussions on Versant Venture Management, LLC

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.